𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pneumocystis jiroveci (Carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease

✍ Scribed by Mimouna Seddik; Hugues Meliez; David Seguy; Nathalie Viget; Antoine Cortot; Jean Frederic Colombel

Book ID
110086233
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
142 KB
Volume
10
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Severe Legionella pneumophila pneumonia
Severe Legionella pneumophila pneumonia following infliximab therapy in a patient with Crohn's disease
✍ Florian Beigel; Matthias JΓΌrgens; Levent Filik; Lutz Bader; Christian LΓΌck; Burk πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 225 KB πŸ‘ 1 views

## Background: Immunosuppressive therapy with anti-tnf-alpha antibodies is effective in patients with inflammatory bowel disease (ibd). however, there is an increased risk for infections associated with this therapy. ## Methods: Here, we report the case of a 58-year-old patient with crohn's disea

Effects of infliximab therapy on abdomin
Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease
✍ Erika Parmentier-Decrucq; Alain Duhamel; Olivier Ernst; Catherine Fermont; Alexa πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 224 KB πŸ‘ 1 views

## Background: Tumor necrosis factor is an adipocytokine possessing a well-established lipolytic effect. in crohn's disease (cd) patients, infliximab therapy may thus result in visceral fat accumulation, which is associated with an increased risk of metabolic syndrome. ## Methods: A total of 132